Patent · US Active

Peptide inhibitor of TGF-β growth factors

US7402566B2 · kind B2 · utility

0Cited by
0References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 17, 2004
Grant dateJul 22, 2008
Priority date
Expiry dateJun 4, 2026

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/858
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A potent peptide inhibitor (SuperSog) of TGF-β family growth factor signaling, peptide variants thereof and nucleotide coding sequences therefore are provided by the invention. The Super-Sog peptide comprises a fragment of the Drosophilia short gastrulation (Sog) gene which includes the CR-1 cysteine-rich repeat of Sog. Methods and compositions for use of Super-Sog in therapeutic and diagnostic applications are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.